Qinecsa

Advancing drug safety solutions to the next level

[Qinecsa @qinecsa]

🎗️ Today on Rare Disease Day 2025, we stand in solidarity with the 300 million people worldwide living with rare diseases. At Qinecsa, patient safety is at the core of everything we do. Together, let’s continue advocating for better support. Learn more at: https://t.co/1cjJzUmZdv

[Qinecsa @qinecsa]

Missed our webinar on #LiteratureScreening last week? The recording is now available! Learn about tackling industry challenges, leveraging AI and automation, and staying ahead of emerging trends in literature screening. Watch the full webinar here: https://t.co/RLY2KJcmGf

[Qinecsa @qinecsa]

💡 Read the PRAC meeting highlights from 10-13 February 2025. At its monthly meeting, the EMA's safety committee (PRAC) carried out its broad range of responsibilities, which cover the risk management of the use of medicines. Read the full highlights: https://t.co/i8BN89XXkM

[Qinecsa @qinecsa]

Qinecsa is Exhibiting at #DIAEurope2025! We're excited to announce our participation at the DIA Global Annual Meeting 2025 in Basel, 18–20 March. If you're attending, be sure to stop by booth #E2 and meet our experts. Set up a meeting in advance: https://t.co/9R36iaqbEW

[Qinecsa @qinecsa]

We're delighted to introduce Mark Parker as #Qinecsa's new Account Director! With 21 years of Life Science Business Development experience, including 13 years in the PV IT space, Mark brings strong expertise in delivering innovative solutions to our global healthcare clients.

[Qinecsa @qinecsa]

🚨 Less than 24 hours to go! Don't miss your chance to join our exclusive webinar on: "Revolutionizing Literature Screening – Challenges, Innovations, and Future Trends." Secure your spot now! 👉 https://t.co/beUEu3m84K

[Qinecsa @qinecsa]

🎯 Thought leadership from Adam Sherlock continues! Our CEO contributes valuable insights in BioPharm International's 'Innovation Accelerates into the Future' feature. 🔗 Read the full article: https://t.co/rcH5ikCt0r

[Qinecsa @qinecsa]

🎯 Industry Perspective - our CEO Adam Sherlock shares: "Moving into 2025, the technology agenda for the bio/pharma industry can be viewed in two dimensions" To read more: https://t.co/LiDLoFhx4u
#AI #Acquisitions #MarketTrends #LifeSciences #PharmaTech #Innovation #Qinecsa

[Qinecsa @qinecsa]

⏳ Only 1 week left to register! Time is running out, secure your spot for our focused 30-minute webinar on Tue 18 Feb: "Revolutionizing Literature Screening – Challenges, Innovations, and Future Trends." Don’t miss out – register now! https://t.co/0oIm4n2CnO

[Qinecsa @qinecsa]

On 31st January 2025, the EU Clinical Trials Regulation (EU-CTR 536/2014) will fully replace the existing Directive (2001/20/EC). This milestone aims to streamline clinical trial processes, boost transparency, and enhance the EU's competitiveness in drug development.

[Qinecsa @qinecsa]

🔎 Pharmacovigilance is evolving — why HALOPV? Acting as an intelligent automation layer, HALOPV complements established safety databases by streamlining workflows, improving compliance, & reducing manual effort in pharmacovigilance operations. Talk to us:https://t.co/q5THNzfZKi

[Qinecsa @qinecsa]

Pharmaceutical Technology continues its insightful conversation with Qinecsa Solutions ' Adam Sherlock examining how shifting political landscapes in the US and Europe could reshape the bio/pharma industry in 2025.
🎥 our industry outlook interview here: https://t.co/40G6fTkiLA

[Qinecsa @qinecsa]

Meet Dr. Preeti Verma, a #pharmacovigilance expert with 20+ years of experience in literature screening. Join our 30-min webinar on Feb 18 to explore regulatory trends, global surveillance, and AI-driven automation in #LiteratureScreening. Register now! https://t.co/qqb7H6v0Ff

[Qinecsa @qinecsa]

This week, the #QinecsaIndia offices welcomed Adam Sherlock, John Cogan, and Kevin Budge! Their visit was marked by two significant traditions—lighting the lamp and planting trees, to reflect knowledge and new beginnings. Big thanks to the India team for their warm hospitality!

[Qinecsa @qinecsa]

💡 Industry Insights - Pharmaceutical Technology talks to Qinecsa Solutions CEO, Adam Sherlock about the outlook for the Life Sciences industry in 2025.
👉You can watch the video interview here https://t.co/RF4Zzh2oih
#pharmacovigilance #megatrends #AI #GLP1 #pricing #Qinecsa

[Qinecsa @qinecsa]

🌐 Live from DIA in Baltimore with the Qinecsa team! Drop by Booth #202 to explore how our end-to-end pharmacovigilance solutions and cutting-edge technologies can revolutionize patient safety.
This is the perfect chance to learn about everything Qinecsa has to offer. #GPVRMS25

[Qinecsa @qinecsa]

Reportum: the leading digital-first PV intake tool with mobile reporting, multi-language support, and 10+ years of proven reliability. With over 10 years of proven reliability, it ensures high-quality data and stronger safety profiles. Schedule a demo: https://t.co/nB1T6oGIxu.

[Qinecsa @qinecsa]

🚨 1 week to go until DIA GPVRMS 2025! If you are planning to attend DIA's Pharmacovigilance and Risk Management Strategies conference, be sure to visit Qinecsa at Booth 202 to experience first-hand our latest advancements in end-to-end pharmacovigilance technology and solutions.

[Qinecsa @qinecsa]

PRAC Meeting Highlights: A review of medicines containing semaglutide has began following concerns regarding an increased risk of developing NAION, a rare eye condition, as suggested in two recent observational studies. Read the full meeting highlights: https://t.co/SGgpfknaFc

[Qinecsa @qinecsa]

We're advancing our innovation capabilities as we welcome Martin as our Chief Technology & Innovation Officer! With 20 years of experience in Life Sciences and as former CEO of Insife, Martin brings exceptional expertise in pharmacovigilance and digital transformation to our team